Drug Trial Radar · NCT01960075
Established Status Epilepticus Treatment Trial
Last checked: Nov 20, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
478
Actual
Start
Oct 2015
Primary completion
Feb 2019
Study completion May 2019
Sponsor
- Lead sponsor
- University of VirginiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Michigan; Medical University of South Carolina; Children's National Research Institute; University of Minnesota; National Institute of Neurological Disorders and Stroke (NINDS)
- First posted
- Oct 10, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to determine the most effective and/or the least effective treatment of benzodiazepine-refractory status epilepticus (SE) among patients older than 2 years. There are three active treatment arms being compared: fosphenytoin (FOS),levetiracetam (LEV), and valproic acid (VPA). The second objective is comparison of three drugs with respect to secondary outcomes. The final objective is to ensure that the trial is informative for treatment of established SE in children by describing the effectiveness, safety, and rate of adverse reactions of these drugs in children.
Conditions
- Benzodiazepine Refractory Status Epilepticus
Interventions
FosphenytoinDrug
LevetiracetamDrug
Valproic acidDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinical Cessation of Status Epilepticus - Intention to TreatTime frame: Within 60 minutes after the start of study drug infusion
- Number of Participants With Clinical Cessation of Status Epilepticus - Per-protocol AnalysisTime frame: Within 60 minutes after the start of study drug infusion
- Number of Participants With Clinical Cessation of Status Epilepticus - Adjudicated Outcomes AnalysisTime frame: Within 60 minutes after the start of study drug infusion
Locations
65 sites in 1 country. Site status is shown where the registry gives one.
Banner University Medical Center - South Campus
Tucson, Arizona
Banner University Medical Center-Tucson Campus
Tucson, Arizona
Ronald Reagan UCLA Medical Center
Los Angeles, California
UC Davis Children's Hospital
Sacramento, California
San Francisco General Hospital
San Francisco, California
UCSF Medical Center
San Francisco, California
UCSF Benioff Children's Hospital
San Francisco, California
Stanford University Medical Center
Stanford, California
Christiana Hospital
Newark, Delaware
A.I.DuPont Hospital for Children
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Grady Memorial Hospital
Atlanta, Georgia
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia
University of Kentucky Hospital
Lexington, Kentucky
University of maryland Medical Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
C.S. Mott Children's Hospital
Ann Arbor, Michigan
University of Michigan Medical Center
Ann Arbor, Michigan
Children's Hospital of Michigan
Detroit, Michigan
Detroit Receiving Hospital
Detroit, Michigan
Henry Ford Hospital
Detroit, Michigan
Sinai-Grace Hospital
Detroit, Michigan
Fairview Southdale Hospital
Edina, Minnesota
Hennepin County Medical Center
Minneapolis, Minnesota
University of Minnesota Medical Center
Minneapolis, Minnesota
University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota
Regions Hospital
Saint Paul, Minnesota
St. Louis Children's Hospital
St Louis, Missouri
Hackensack University Medical Center
Hackensack, New Jersey
Kings County Hospital Center
Brooklyn, New York
SUNY Downstate Medical Center
Brooklyn, New York
Maimonides Medical Center
Brooklyn, New York
NYP Columbia University Medical Center
New York, New York
NYP Morgan Stanley Children's Hospital
New York, New York
University of Cincinnati Medical Center
Cincinnati, Ohio
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Nationwide Children's Hospital
Columbus, Ohio
OSU Wexner Medical Center
Columbus, Ohio
Oregon Health & Science University Hospital
Portland, Oregon
Crozer-Chester Medical Center
Chester, Pennsylvania
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.